December 1-3, the 45th international quality management group meeting successfully concluded. In this meeting, the 4 QC team topics that Yangzijiang Pharmaceutical selected to participate in all won the Platinum Prize, the highest award, which is also the six consecutive years that Yangzijiang Pharmaceutical has won gold and silver in the international QC competition. Since 2015, Yangzijiang has won 24 international QC gold awards in all previous international quality conferences.

The International Convention on Quality Control Circles (ICQCC) has been held 45 times since its first meeting in 1976. It is the international QC activity with the largest scale, the broadest scope and the strongest cohesion in the field of quality management, known as the "Olympics of Quality". Participate in this platform for the publication of QC results, to pass through the national layers of screening, on behalf of the highest level of quality management.

Affected by the COVID-19 epidemic, the 45th International Quality Management Group Meeting was published online. More than 260 teams from 8 countries and regions including China, South Korea, Singapore and Bangladesh participated in the meeting. Publicians of 66 topics from 47 enterprises including China Aerospace, State Grid, China Nuclear Power, China Tobacco, Gree and Yangzijiang Pharmaceutical gathered in Beijing to participate in online publishing on behalf of various industries in China. The 4 topics organized by Yangzijiang Pharmaceutical all won gold MEDALS, realizing the Grand Slam.

The Fifth Plenary Session of the 19th CPC Central Committee proposed that the "14th Five-Year" period of economic and social development should be based on the promotion of high-quality development as the theme. In order to implement the spirit of the 19th CPC National Congress and the guiding opinions of the CPC Central Committee and the State Council on carrying out quality improvement actions, Yangzijiang Pharmaceutical continued to vigorously carry out QC group activities. The results of QC team will become a powerful weapon to effectively promote the upgrading of the quality management level of enterprises. At the same time, it will actively give out China's voice on the international quality stage and enhance the discourse power and influence of China pharmaceutical in the field of international quality.

In the subject that we participated in and published this time, the QC team of our company successfully realized nitrogen filling in the whole process of lyophilized production through independent research on the design and application of nitrogen filling device in the automatic feeding and unloading system of lyophilized powder needles, and opened up the key link of internationalization of the production workshop. The QC team of Hatz Biological Chenxi has taken reducing the content of impurity Ⅰ in the API of a product as the key task, successfully reaching the original research standards and reaching the intention of exporting to European and American countries. The QC team of Guangzhou Hailui Pharmaceutical Co., Ltd. Zhiyuan solved the problem of fitting the dissolution curve of product A for venous thrombosis and accelerated its approval process. Wuji QC team of the joint-stock company focused on the technical difficulties in the expanded batch production process of Sanfengtongqiao dripping pills, reduced the burning residue of its extract, achieved the batch expansion, met the market supply demand, and benefited more rhinitis patients.

Yangzijiang Pharmaceutical has always adhered to the principle of "quality first, benefit first", and adhered to the quality culture of "pharmaceutical for parents, pharmaceutical for loved ones". In the company's quality management system, QC team activities play a key role in improving quality. In the future, Yangzijiang Pharmaceutical will continue to strengthen the quality awareness of all staff, take the international advanced quality management system as the benchmark, and build "Yangzijiang" into a world-class quality brand, winning glory for the national medicine industry. Source: Group News